Fig. 3

Changes in liver function at different times of treatment. a/b At 1 W, the levels of AST and ALT in the single TACE treatment group and in the TACE-MWA group increased significantly and gradually returned to the original level at 1 M and 3 M. c At 1 W, TBIL levels in the TACE group and the TACE-MWA group were significantly increased and continued to decrease following 1 M of treatment. d The ALB levels in the TACE group were decreased slightly within 1 week, while the ALB levels continued to increase following treatment in the TACE-MWA group. However, the two groups reached normal levels in M3. M0, pretreatment; 1 W, the first week following treatment; 1 M, the first month following treatment; 3 M, the third month following treatment. ALB, Albumin; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; TBIL, Total bilirubin